stride study semaglutide Walking Further Toward the Future: and Functional Recovery in PAD- the Trial ACC 2025. STRIDE: Semaglutide en

: 2

These trial results relate exclusively to the drug candidate under clinical investigation

Patients experiencing unintentional weight loss beyond expected therapeutic effects , fever, or night sweats alongside digestive symptoms should seek medical assessment, as these may suggest conditions unrelated to semaglutide

Compounded semaglutide: Compounded medications contain the same active ingredient but are customized and mixed at a pharmacy

This means their side-effect profiles overlap, although the frequency and intensity of symptoms may differ because of dose, treatment goals, other medicines, and individual health factors

p-values are derived from Pearson correlation